China approves Ebola vaccine

Business & Technology

A summary of the top news in Chinese business and technology for October 20, 2017. Part of the daily The China Project newsletter, a convenient package of Chinaโ€™s business, political, and cultural news delivered to your inbox for free. Subscribe here.


Caixinย reportsย that the China Food and Drug Administration (CFDA) has approved a vaccine for Ebola, the contagious virus that killed more than 10,000 people in an outbreak in West Africa in 2014 and 2015. The vaccine was developed by the Bioengineering Institute of the Chinese Academy of Military Medical Sciences and private drugmaker Tianjin CanSino Biotechnology. Caixinย says the vaccine is freeze-dried, โ€œwhich makes it particularly stable during transport.โ€

In late 2016, Russia approved the first vaccine against Ebola. Global pharma giants Merck, Johnson & Johnson, and GlaxoSmithKline are also developing Ebola vaccines.

Taiwan investigates Singapore gaming company for Tencent link

Sea, a Singapore-based online games and ecommerce business, has raised $1 billion in advance of a New York listing. The Financial Timesย reportsย (paywall) that the company is now under investigation in Taiwan over allegations that it did not disclose its links to China โ€” Tencent has a 39.8 percent stake in Sea. About a third of Seaโ€™s revenues are from Taiwan.